Pharmacokinetics of antiarrhythmic drugs
Kock-Weser, J.
Cardiovascular Clinics 7(2): 191-202
1975
ISSN/ISBN: 0069-0384 PMID: 1104167 Document Number: 88557
Document emailed within 1 workday
Related Documents
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355Usuda, K.; Ikeda, T. 1991: Drug induced arrhythmias (digitalis, antiarrhythmic drugs and other drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2666-2671
Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Weiss, M.; Sziegoleit, W.; Machill, K.; Hafemeister, G.; Förster, W. 1980: Relationship between the pharmacokinetics of a short-acting antiarrhythmic drug and its effects: studies with Falirytmin International Journal of Clinical Pharmacology Therapy and Toxicology 18(6): 237-241
Ignat'ev, M.V. 1975: Some new antiarrhythmic drugs Voenno-Meditsinskii Zhurnal 1: 73-74
Coumel, P.; Thomas, O. 1997: Antiarrhythmic drugs: how to use and to evaluate them Le Journal Medical Libanais. Lebanese Medical Journal 45(4): 221-223
Hoffman, B.F. 1997: Arrhythmias and antiarrhythmic drugs Mount Sinai Journal of Medicine new York 64(2): 136-141
Mehta, D.; Saxena, A. 1990: Safety of use of antiarrhythmic drugs Indian Heart Journal 42(6): 445-450
Somani, P.; Simon, V.A.; McManus, K. 1985: Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion Canadian Journal of Cardiology 1(1): 56-65
Harrison, D.C.; Irwin, W.G. 1981: New concepts for antiarrhythmic drugs in the 1980's Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 73-77
Reiffel, J.A. 2001: Issues in the use of generic antiarrhythmic drugs Current Opinion in Cardiology 16(1): 23-29
Goldberg, P.B.; Stoner, S.A.; Roberts, J. 1978: Influence of age on activity of antiarrhythmic drugs in rat heart Advances in Experimental Medicine and Biology 97: 309-313
Caillard, C.G.; Louis, J.C. 1980: Assessment of antiarrhythmic drugs in experimental pharmacology Methods and Findings in Experimental and Clinical Pharmacology 2(5): 223-252
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Adams, H.R. 1986: New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs Journal of the American Veterinary Medical Association 189(5): 525-532
Goedel-Meinen, L.; Schmidt, G.; Jahns, G.; Klein, G.; Wirtzfeld, A.; Baedeker, W.; Blömer, H. 1986: Antiarrhythmic drugs in advanced organic heart disease British Journal of Clinical Practice. Suppl 44: 28-30
Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M. 2005: Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 169-174
Yamashita, T.; Sugimoto, T. 1991: Medical management of arrhythmias; newer antiarrhythmic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2680-2686
Josephson, M.A.; Singh, B.N. 1986: Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs Angiology 37(12 Part 2): 950-958